VLA
Click for more information
0.00% $1.75 viralytics limited

Ann: New Data at SITC Meeting. Further Studies Announced, page-53

  1. DavieJones
    245 Posts.
    lightbulb Created with Sketch. 20
    clock Created with Sketch.
    16/11/17
    15:30
    Post #: 28858724
    Hi Lopez

    From the SITC 2017 abstracts (O41 on pages 108/109), the BMS trial of its IDO1 & Opdivo combo resulted in 11% Grade 3/4 SAEs and another 2% discontinuation from drug toxicity (including a death) from 216 patients.

    https://higherlogicdownload.s3.amaz...nual Meeting 2017/SITC_2017_Abstract_Book.pdf

    So it looks like the IV Cavatak/Keytruda combo has a slightly better safety profile (& more importantly, no toxicity-related deaths !)

    Cheers
    VLA Price at posting: 76.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.